Slawomir Poletajew

19PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersNephrology and urologyMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Mar 13, 2025
A Simple Nomogram to Predict Clinically Significant Prostate Cancer at MRI-Guided Biopsy in Patients with Mild PSA Elevation and Normal DRE.

Hubert Kamecki, Andrzej Tokarczyk, Małgorzata Dębowska

|Sep 27, 2024
Role of Systematic Biopsy in the Era of Targeted Biopsy: A Review.

Wojciech Malewski, Tomasz Milecki, Omar Tayara

|Aug 28, 2024
Prostate-Specific Membrane Antigen Expression in Patients with Primary Prostate Cancer: Diagnostic and Prognostic Value in Positron Emission Tomography-Prostate-Specific Membrane Antigen.

Omar Tayara, Sławomir Poletajew, Wojciech Malewski

|Nov 25, 2023
Quantification of Gleason Pattern 4 at MRI-Guided Biopsy to Predict Adverse Pathology at Radical Prostatectomy in Intermediate-Risk Prostate Cancer Patients.

Hubert Kamecki, Łukasz Mielczarek, Stanisław Szempliński

|Nov 02, 2023
Glycosaminoglycan Replacement Therapy with Intravesical Instillations of Combined Hyaluronic Acid and Chondroitin Sulfate in Patients with Recurrent Cystitis, Post-radiation Cystitis and Bladder Pain Syndrome: A Narrative Review.

Sławomir Poletajew, Magdalena M Brzózka, Wojciech Krajewski

|Jan 08, 2023
Predictors of Clinically Significant Prostate Cancer in Patients with PIRADS Categories 3-5 Undergoing Magnetic Resonance Imaging-Ultrasound Fusion Biopsy of the Prostate.

Stanisław Szempliński, Hubert Kamecki, Małgorzata Dębowska

Pageof 4

Frequent Collaborators

9 joint publications

Piotr Kryst

2 joint publications

Hubert Kamecki

2 joint publications

Łukasz Nyk

2 joint publications

Omar Tayara